scispace - formally typeset
H

Heike Engel

Researcher at University of Texas MD Anderson Cancer Center

Publications -  10
Citations -  1069

Heike Engel is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Leukemia & Bone marrow. The author has an hindex of 8, co-authored 10 publications receiving 1059 citations.

Papers
More filters
Journal ArticleDOI

Allogeneic Blood Stem Cell Transplantation for Refractory Leukemia and Lymphoma: Potential Advantage of Blood Over Marrow Allografts

TL;DR: Cryopreserved, filgrastim-stimulated allogeneic PBSCs may be a suitable alternative to allogenic marrow for transplantation with the advantage of more rapid platelet recovery, and further studies are required to assess long-term risks of chronic GVHD.
Journal ArticleDOI

Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

TL;DR: Forty-one normal donors were studied to assess the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on the peripheralization of hematopoietic progenitor cells and lymphoid subsets and the actuarial probability of developing acute GVHD.
Journal Article

Retinoic Acid-induced Expression of CD38 Antigen in Myeloid Cells Is Mediated through Retinoic Acid Receptor-α

TL;DR: It is concluded that CD38 is ATRA inducible in myeloid leukemia cells and normal CD34 + bone marrow cells, suggesting a similar role for RARα in CD38 expression in other hematopoietic cells.
Journal ArticleDOI

Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells

TL;DR: Cox regression analysis showed that cytogenetic class and levels of clonal cells at CR were related to time to relapse and the level of MRD identified patients at high and low risk of relapse.